ERBB2 and breast cancer: HER2-positive; operable (T2–3, N0–1, M0), locally advanced (T2–3, N2–3, M0 or T4a–c, any N, M0), or inflammatory (T4d, any N, M0) BC with primary tumors larger than 2 cm in diameter (n = 417)